© 2019 Wolters Kluwer Health, Inc. All rights reserved. www.epidem.com | e15 Assessing ExposureResponse Trends Using the Disease Risk Score REFERENCES 1. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373–383. 2. Klabunde CN, Potosky AL, Legler JM, Warren JL. Development of a comorbidity index using physician claims data. J Clin Epidemiol. 2000;53:1258–1267. 3. Elixhauser A, Steiner C, Harris DR, Coffey RM. Comorbidity measures for use with administrative data. Med Care. 1998;36:8–27. 4. National Cancer Institute Comorbidity SAS Macro (2000 version). 2000. https://healthcaredelivery.cancer.gov/seermedicare/considerations/macro-2000.html. Accessed 14 June 2019. 5. KPWHRI – Charlson Macro. 2019. https:// github.com/kpwhri/CharlsonMacro. Accessed 25 June 2019. 6. Medicare Chronic Conditions Warehouse, Chronic Condition Charts, 2007-2016 – Endocrine and renal conditions. 2018. https:// www.ccwdata.org/web/guest/medicare-charts/ medicare-chronic-condition-charts/#b2_endo_ renal_2007_2016. Accessed 05 June 2019. 7. Murphy D, McCulloch CE, Lin F, et al. Trends in prevalence of chronic kidney disease in the United States. Ann Intern Med. 2016;165:473–481. 8. National Kidney Disease Education Program, NKDEP Laboratory Working Group. Creatinine Standardization. https://www.niddk.nih.gov/health-information/communication-programs/nkdep/laboratory-evaluation/ glomerular-filtration-rate/creatinine-standardization. n.d Accessed 21 July 2019.
[1]
Deepak L. Bhatt,et al.
On the use of propensity scores in case of rare exposure
,
2016,
BMC Medical Research Methodology.
[2]
Sebastian Schneeweiss,et al.
Role of disease risk scores in comparative effectiveness research with emerging therapies
,
2012,
Pharmacoepidemiology and drug safety.
[3]
W. Ray,et al.
Use of disease risk scores in pharmacoepidemiologic studies
,
2009,
Statistical methods in medical research.
[4]
Clive Osmond,et al.
Statistical Methods in Cancer Research, Vol. 2, the Design and Analysis of Cohort Studies
,
1990
.
[5]
J. Higginson.
International Agency for Research on Cancer.
,
1968,
WHO chronicle.